Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1218
-
Total 13F shares, excl. options
-
216M
-
Shares change
-
-613K
-
Total reported value, excl. options
-
$82.5B
-
Value change
-
-$203M
-
Put/Call ratio
-
0.88
-
Number of buys
-
520
-
Number of sells
-
-519
-
Price
-
$381.80
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2021
1,345 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2021.
Elevance Health, Inc. - Common Stock (ELV) has 1,218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 216M shares
of 226M outstanding shares and own 95.7% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21.6M shares), VANGUARD GROUP INC (18.9M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.2M shares), WELLINGTON MANAGEMENT GROUP LLP (10.7M shares), STATE STREET CORP (10.5M shares), FMR LLC (6.95M shares), Capital International Investors (4.62M shares), BAILLIE GIFFORD & CO (4.03M shares), GEODE CAPITAL MANAGEMENT, LLC (3.96M shares), and BANK OF AMERICA CORP /DE/ (3.76M shares).
This table shows the top 1218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.